In vitro stability and metabolism of salvinorin A in rat plasma.
about
Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesNeuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin AReal-time bioluminescence imaging of glycans on live cells.New drugs of abuse.Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel.Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence.LC-MS/MS quantification of salvinorin A from biological fluids.Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.Hansen solubility parameters for assay method optimization of simvastatin, ramipril, atenolol, hydrochlorothiazide and aspirin in human plasma using liquid chromatography with tandem mass spectrometry.In vitro stability and metabolism of O2', O3', O5'-tri-acetyl-N6-(3-hydroxylaniline) adenosine in rat, dog and human plasma: chemical hydrolysis and role of plasma esterases.Validation of a Rapid and Sensitive UPLC-MS-MS Method Coupled with Protein Precipitation for the Simultaneous Determination of Seven Pyrethroids in 100 µL of Rat Plasma by Using Ammonium Adduct as Precursor Ion.Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor.Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene.Analysis of Salvinorin A in urine using microextraction in packed syringe and GC-MS/MS.The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs.Modular Approach to pseudo-Neoclerodanes as Designer κ-Opioid Ligands.
P2860
Q24631675-91F882DE-BC49-4861-AD15-98E4A1B9DC67Q30467220-87E1171F-944A-4759-9063-366D3879C51BQ33932166-DBAC3801-D888-4906-9E4D-6A06D32D2841Q34451886-9E9D7E80-A699-456C-9D46-A8F8DA108649Q36069379-4A01CA54-F1DB-40A3-8E1C-9CF33132D950Q37349384-60BB11CD-B327-4D55-A5D1-9107F624CAAEQ37451366-794795F0-4C7C-4CC4-9547-4A94B1BED89AQ38116484-49CD639B-4A81-4EA5-8AE1-67E22C494E9CQ38655367-69FB5D3C-FB79-4659-B593-8EF15DFF1703Q39761375-D08AE860-8B35-4F46-9D64-F32D7EE36530Q42751400-C87F1952-DED6-4B07-8FAF-CD46BB13739BQ43125212-7907A588-B1C4-4B81-98CC-A33B61389C05Q44344643-B94A4730-19E9-47F4-A7CC-295E7EFB2301Q44347299-38E66647-3CFF-4E77-B74C-7D674776F506Q46178251-0D8FA99A-14FE-4B99-A1E5-9879ECEE98E9Q46831381-43F4E5B8-A4EF-44B1-A672-53D340B20822Q47878237-78A68DA3-CE44-4EC2-8412-9506AEBD4434Q48113763-46A5C7F0-4A78-4815-8F81-4B147ABB715AQ50591898-B9B4752C-5117-4BC9-8632-EC1D5AC015A8
P2860
In vitro stability and metabolism of salvinorin A in rat plasma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
In vitro stability and metabolism of salvinorin A in rat plasma.
@en
In vitro stability and metabolism of salvinorin A in rat plasma.
@nl
type
label
In vitro stability and metabolism of salvinorin A in rat plasma.
@en
In vitro stability and metabolism of salvinorin A in rat plasma.
@nl
prefLabel
In vitro stability and metabolism of salvinorin A in rat plasma.
@en
In vitro stability and metabolism of salvinorin A in rat plasma.
@nl
P2093
P2860
P1433
P1476
In vitro stability and metabolism of salvinorin A in rat plasma.
@en
P2093
P2860
P304
P356
10.1080/00498250902769967
P407
P577
2009-05-01T00:00:00Z